These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35088185)

  • 1. Differential Diagnosis and Molecular Stratification of Gastrointestinal Stromal Tumors on CT Images Using a Radiomics Approach.
    Starmans MPA; Timbergen MJM; Vos M; Renckens M; Grünhagen DJ; van Leenders GJLH; Dwarkasing RS; Willemssen FEJA; Niessen WJ; Verhoef C; Sleijfer S; Visser JJ; Klein S
    J Digit Imaging; 2022 Apr; 35(2):127-136. PubMed ID: 35088185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT texture analysis can be a potential tool to differentiate gastrointestinal stromal tumors without KIT exon 11 mutation.
    Xu F; Ma X; Wang Y; Tian Y; Tang W; Wang M; Wei R; Zhao X
    Eur J Radiol; 2018 Oct; 107():90-97. PubMed ID: 30292279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of a Radiomics Nomogram Model Based on Contrast-Enhanced Computed Tomography for KIT Exon 9 Gene Mutation in Gastrointestinal Stromal Tumors.
    Wei Y; Lu Z; Ren Y
    Technol Cancer Res Treat; 2023; 22():15330338231181260. PubMed ID: 37296525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
    J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of high Ki-67 proliferation index of gastrointestinal stromal tumors based on CT at non-contrast-enhanced and different contrast-enhanced phases.
    Xie Z; Suo S; Zhang W; Zhang Q; Dai Y; Song Y; Li X; Zhou Y
    Eur Radiol; 2024 Apr; 34(4):2223-2232. PubMed ID: 37773213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of contrast-enhanced CT based radiomic machine learning algorithm in differentiating gastrointestinal stromal tumors with KIT exon 11 mutation: a two-center study.
    Liu B; Liu H; Zhang L; Song Y; Yang S; Zheng Z; Zhao J; Hou F; Zhang J
    Diagn Interv Radiol; 2022 Jan; 28(1):29-38. PubMed ID: 35142612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography-based radiomics model for discriminating the risk stratification of gastrointestinal stromal tumors.
    Zhang L; Kang L; Li G; Zhang X; Ren J; Shi Z; Li J; Yu S
    Radiol Med; 2020 May; 125(5):465-473. PubMed ID: 32048155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
    Jašek K; Váňová B; Grendár M; Štanclová A; Szépe P; Hornáková A; Holubeková V; Plank L; Lasabová Z
    Pathol Res Pract; 2020 Nov; 216(11):153171. PubMed ID: 32836055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CT-based radiomics and deep learning model for predicting risk stratification of gastric gastrointestinal stromal tumors.
    Yang P; Wu J; Liu M; Zheng Y; Zhao X; Mao Y
    Med Phys; 2024 Oct; 51(10):7257-7268. PubMed ID: 38935330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of an Italian series of sporadic GISTs.
    Origone P; Gargiulo S; Mastracci L; Ballestrero A; Battistuzzi L; Casella C; Comandini D; Cusano R; Dei Tos AP; Fiocca R; Garuti A; Ghiorzo P; Martinuzzi C; Toffolatti L; ; Bianchi Scarrà G
    Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
    Peterson MR; Piao Z; Weidner N; Yi ES
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Capelli L; Petracci E; Quagliuolo V; Saragoni L; Colombo P; Morgagni P; Calistri D; Tomezzoli A; Di Cosmo M; Roviello F; Vindigni C; Coniglio A; Villanacci V; Catarci M; Coppola L; Alfieri S; Ricci R; Capella C; Rausei S; Gulino D; Amadori D; Ulivi P;
    Eur J Surg Oncol; 2016 Aug; 42(8):1206-14. PubMed ID: 27265040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M; Lasota J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 18. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.
    Rossi S; Gasparotto D; Miceli R; Toffolatti L; Gallina G; Scaramel E; Marzotto A; Boscato E; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Mariani L; Amore P; Gronchi A; Casali PG; Maestro R; Dei Tos AP
    Am J Surg Pathol; 2015 Jul; 39(7):922-30. PubMed ID: 25970686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance.
    Zheng S; Huang KE; Pan YL; Zhou Y; Pan SD; Li X; Jia J; Zheng XL; Tao DY
    Gastric Cancer; 2015 Oct; 18(4):796-802. PubMed ID: 25182956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.